Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors [Phase 1, Phase 2]
A pharmacokinetic study evaluating the combination of lurbinectedin and irinotecan in selected solid tumors has completed (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Biomarker Screening Protocol for Participants With Solid Tumors
A clinical trial update describes a biomarker screening protocol for participants with solid tumors, and the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules [Phase 1]
This Phase 1 trial evaluates increasing doses and different treatment schedules of the AKT inhibitor AZD5363 (ipatasertib) in patients with …
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach [Phase 2]
This update notes termination of the Phase 2 UPPROACH trial evaluating upfront intensity-modulated proton beam therapy for endometrial cance…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer [Phase 2]
Phase 2 study of pembrolizumab in ultramutated and hypermutated endometrial cancer has completed; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: An Endometrial Cancer Chemoprevention Study of Metformin [Phase 3]
Phase 3 clinical trial evaluating metformin for endometrial cancer chemoprevention has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients [EARLY_Phase 1]
Early-phase clinical trial investigating the effects of a PARP inhibitor on the tumor microenvironment in high-risk endometrial cancer has c…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer [Phase 2]
Phase 2 clinical trial of exemestane in patients with complex atypical hyperplasia of the endometrium, endometrial intraepithelial neoplasia…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer [Phase 1]
Phase 1 trial evaluating durvalumab and tremelimumab with radiotherapy in recurrent or metastatic gynecologic cancers has been terminated; n…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) [Phase 2]
Phase 2 EndoBARR trial evaluating endometrial cancer with bevacizumab, atezolizumab, and rucaparib has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer [Phase 2]
This notice describes a Phase 2 trial evaluating the combination of TQB2450 and Anlotinib hydrochloride capsule in advanced endometrial canc…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis [Phase 1]
Phase 1 study evaluating nivolumab with or without ipilimumab in patients with recurrent or high-grade gynecologic cancers and metastatic pe…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) [Phase 2]
A Phase 2 trial evaluating mirvetuximab soravtansine in combination with pembrolizumab for endometrial cancer has posted results (as of May …
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Bariatric Education for Women With Obesity and Endometrial Cancer
The University of Oklahoma-sponsored clinical trial on bariatric education for women with obesity and endometrial cancer has been terminated…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Atezolizumab Trial in Endometrial Cancer - AtTEnd [Phase 3]
Phase 3 trial of atezolizumab in endometrial cancer (AtTEnd) has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: FitEx for Endometrial Cancer Survivors: Initial Efficacy [NA]
The completed clinical trial evaluating FitEx for endometrial cancer survivors reported initial efficacy results, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study of PF-07260437 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PF-07260437 in advanced or metastatic solid tumors was terminated, with results posted on 2025-05-06.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Study of LY2880070 in Participants With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Esperas Pharma completed a Phase 1/2 study of LY2880070 in adults with advanced or metastatic cancer, including colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors [NA]
A completed clinical trial evaluating the Carevive Survivor Care Planning System for improving quality of life in breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer [NA]
This clinical trial update reports on caloric restriction before surgery for patients with breast cancer, endometrial cancer, or prostate ca…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer [Phase 3]
Phase 3 clinical trial update on intraoperative TAP block and postoperative pain control for minimally invasive hysterectomy in endometrial …
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer [NA]
A completed clinical trial evaluating the impact of a physical activity intervention in overweight and obese patients with endometrial cance…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging [Phase 1, Phase 2]
An early-phase study evaluating bone marrow-sparing, image-guided radiation therapy for cervical and endometrial cancer using G-CSF support …
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
A completed clinical trial update reports that OC Detect improves early diagnosis for ovarian and endometrial cancers.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating QL1706-based therapy in advanced endometrial cancer patients who progressed after PD-1/PD-L1 therapy; curr…